In the current study, we identified a novel onco-fetal molecule galectin-14 in HCC by a single cell clone-based screening, and demonstrated that galectin-14 could increase the expression of HSPGs, causing tumor cells sensitize to growth factor and consequently promoting HCC tumor growth. Here, LGALS14 is linked to hepatocellular carcinoma.